COGSTATE LTD — Investor Relations & Filings

Cogstate Ltd is a neuroscience technology company specializing in the development and commercialization of digital brain health assessments. The company provides scientifically validated computerized cognitive tests designed to measure various domains of brain function, including memory, attention, and executive function. Its primary offerings include clinical trial services, where it supports pharmaceutical and biotechnology companies in the recruitment, monitoring, and data analysis of global studies, particularly in therapeutic areas such as Alzheimer’s disease and other neurodegenerative disorders. Additionally, Cogstate offers healthcare solutions for the early detection of cognitive impairment in clinical settings. The company’s technology is characterized by its sensitivity to change, cultural neutrality, and ease of administration across diverse populations, facilitating efficient and standardized cognitive monitoring in both research and clinical practice.